Melanie Ivarsson OBE Joins PhaseV Scientific Advisory Board
Melanie Ivarsson, PhD, OBE, a veteran clinical development leader and former Chief Development Officer at Moderna, has joined the scientific advisory board of PhaseV, a company focused on AI- and machine learning-driven clinical development. Ivarsson’s appointment aligns with PhaseV’s launch of a new platform aimed at improving the operational efficiency of clinical trials using artificial…